Literature DB >> 26001358

[Implantable cardioverter-defibrillator at the end of life].

D Pfeiffer1, A Hagendorff, C Kühne, S Reinhardt, N Klein.   

Abstract

Brady- and tachyarrhythmias at the end of life are common observations. Implantable cardioverter-defibrillators answer with antibrady and antitachycardia pacing, which will not be associated with any complaints of the dying patient. In contrast, defibrillation and cardioversion shocks are extremely painful. Therefore shocks should be inactivated at the end of life. Family doctors, internists, emergency physicians and paramedics are unable to inactivate shocks. Deactivation of shocks at the end of life is not comparable to euthanasia or assisted suicide, but allow the patient to die at the end of an uncurable endstage disease. Deactivation of shocks should be discussed with the patient before initial implantation of the devices. The precise moment of the inactivation at the end of life should be discussed with patients and relatives. There is no common recommendation for the time schedule of this decision; therefore it should be based on the individual situation of the patient. Emergency health care physicians need magnets and sufficient information to inactivate defibrillators. The wishes of the patient have priority in the decision process and should be written in the patient's advance directive, which must be available in the final situation. However the physician must not necessarily follow every wish of the patient. As long as the laws in the European Union are not uniform, German recommendations are needed.

Entities:  

Mesh:

Year:  2015        PMID: 26001358     DOI: 10.1007/s00399-015-0366-6

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  30 in total

Review 1.  [Sudden cardiac death].

Authors:  A Bayés de Luna; J Guindo
Journal:  Med Clin (Barc)       Date:  1989-04-29       Impact factor: 1.725

2.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

3.  Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.

Authors:  James N Kirkpatrick; Maia Gottlieb; Priya Sehgal; Rutuke Patel; Ralph J Verdino
Journal:  Am J Cardiol       Date:  2011-09-22       Impact factor: 2.778

4.  Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.

Authors:  Daniel B Kramer; Aaron S Kesselheim; Dan W Brock; William H Maisel
Journal:  Heart Rhythm       Date:  2010-07-19       Impact factor: 6.343

5.  Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey.

Authors:  Nathan Goldstein; Melissa Carlson; Elayne Livote; Jean S Kutner
Journal:  Ann Intern Med       Date:  2010-03-02       Impact factor: 25.391

6.  Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.

Authors:  Germanas Marinskis; Lieselot van Erven
Journal:  Europace       Date:  2010-08       Impact factor: 5.214

7.  Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation.

Authors:  Anders Agård; Rurik Löfmark; Nils Edvardsson; Inger Ekman
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

8.  Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians.

Authors:  Nathan Goldstein; Elizabeth Bradley; Jessica Zeidman; Davendra Mehta; R Sean Morrison
Journal:  J Am Coll Cardiol       Date:  2009-07-21       Impact factor: 24.094

Review 9.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

10.  "That's like an act of suicide" patients' attitudes toward deactivation of implantable defibrillators.

Authors:  Nathan E Goldstein; Davendra Mehta; Saima Siddiqui; Ezra Teitelbaum; Jessica Zeidman; Magdelena Singson; Elena Pe; Elizabeth H Bradley; R Sean Morrison
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.